Literature DB >> 22281594

Drug discovery: Chemical beauty contest.

Paul Leeson.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22281594     DOI： 10.1038/481455a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  10 in total

1.  The Design of Leadlike Combinatorial Libraries.

Authors: 
Journal:  Angew Chem Int Ed Engl       Date:  1999-12-16       Impact factor: 15.336

2.  A comparison of physiochemical property profiles of development and marketed oral drugs.

Authors:  Mark C Wenlock; Rupert P Austin; Patrick Barton; Andrew M Davis; Paul D Leeson
Journal:  J Med Chem       Date:  2003-03-27       Impact factor: 7.446

3.  Assessment of the consistency of medicinal chemists in reviewing sets of compounds.

Authors:  Michael S Lajiness; Gerald M Maggiora; Veerabahu Shanmugasundaram
Journal:  J Med Chem       Date:  2004-09-23       Impact factor: 7.446

Review 4.  The influence of the 'organizational factor' on compound quality in drug discovery.

Authors:  Paul D Leeson; Stephen A St-Gallay
Journal:  Nat Rev Drug Discov       Date:  2011-09-30       Impact factor: 84.694

5.  Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties.

Authors:  Travis T Wager; Xinjun Hou; Patrick R Verhoest; Anabella Villalobos
Journal:  ACS Chem Neurosci       Date:  2010-03-25       Impact factor: 4.418

6.  Quantifying the chemical beauty of drugs.

Authors:  G Richard Bickerton; Gaia V Paolini; Jérémy Besnard; Sorel Muresan; Andrew L Hopkins
Journal:  Nat Chem       Date:  2012-01-24       Impact factor: 24.427

Review 7.  The influence of drug-like concepts on decision-making in medicinal chemistry.

Authors:  Paul D Leeson; Brian Springthorpe
Journal:  Nat Rev Drug Discov       Date:  2007-11       Impact factor: 84.694

8.  Physiochemical drug properties associated with in vivo toxicological outcomes.

Authors:  Jason D Hughes; Julian Blagg; David A Price; Simon Bailey; Gary A Decrescenzo; Rajesh V Devraj; Edmund Ellsworth; Yvette M Fobian; Michael E Gibbs; Richard W Gilles; Nigel Greene; Enoch Huang; Teresa Krieger-Burke; Jens Loesel; Travis Wager; Larry Whiteley; Yao Zhang
Journal:  Bioorg Med Chem Lett       Date:  2008-07-24       Impact factor: 2.823

9.  Strategies to improve in vivo toxicology outcomes for basic candidate drug molecules.

Authors:  Tim Luker; Lilian Alcaraz; Kamaldeep K Chohan; Niklas Blomberg; Dearg S Brown; Roger J Butlin; Thomas Elebring; Andrew M Griffin; Simon Guile; Stephen St-Gallay; Britt-Marie Swahn; Steve Swallow; Michael J Waring; Mark C Wenlock; Paul D Leeson
Journal:  Bioorg Med Chem Lett       Date:  2011-07-27       Impact factor: 2.823

10.  Getting pharmaceutical R&D back on target.

Authors:  Mark E Bunnage
Journal:  Nat Chem Biol       Date:  2011-06       Impact factor: 15.040
  10 in total
  49 in total

1.  QSAR modeling: where have you been? Where are you going to?

Authors:  Artem Cherkasov; Eugene N Muratov; Denis Fourches; Alexandre Varnek; Igor I Baskin; Mark Cronin; John Dearden; Paola Gramatica; Yvonne C Martin; Roberto Todeschini; Viviana Consonni; Victor E Kuz'min; Richard Cramer; Romualdo Benigni; Chihae Yang; James Rathman; Lothar Terfloth; Johann Gasteiger; Ann Richard; Alexander Tropsha
Journal:  J Med Chem       Date:  2014-01-06       Impact factor: 7.446

2.  Target (In)Validation: A Critical, Sometimes Unheralded, Role of Modern Medicinal Chemistry.

Authors:  Ramzi F Sweis
Journal:  ACS Med Chem Lett       Date:  2015-05-21       Impact factor: 4.345

3.  Fragment virtual screening based on Bayesian categorization for discovering novel VEGFR-2 scaffolds.

Authors:  Yanmin Zhang; Yu Jiao; Xiao Xiong; Haichun Liu; Ting Ran; Jinxing Xu; Shuai Lu; Anyang Xu; Jing Pan; Xin Qiao; Zhihao Shi; Tao Lu; Yadong Chen
Journal:  Mol Divers       Date:  2015-05-29       Impact factor: 2.943

4.  Endocannabinoid Transport Proteins: Discovery of Tools to Study Sterol Carrier Protein-2.

Authors:  Cecilia J Hillard; Huan Huang; Caleb D Vogt; Beatriz E Rodrigues; Terrence S Neumann; Daniel S Sem; Friedhelm Schroeder; Christopher W Cunningham
Journal:  Methods Enzymol       Date:  2017-07-17       Impact factor: 1.600

5.  Stacking with No Planarity?

Authors:  Hakan Gunaydin; Michael D Bartberger
Journal:  ACS Med Chem Lett       Date:  2016-04-06       Impact factor: 4.345

6.  Designing of phenol-based β-carbonic anhydrase1 inhibitors through QSAR, molecular docking, and MD simulation approach.

Authors:  Shahzaib Ahamad; Md Imtaiyaz Hassan; Neeraja Dwivedi
Journal:  3 Biotech       Date:  2018-05-14       Impact factor: 2.406

7.  Small molecule metalloprotease inhibitor with in vitro, ex vivo and in vivo efficacy against botulinum neurotoxin serotype A.

Authors:  Alan R Jacobson; Michael Adler; Nicholas R Silvaggi; Karen N Allen; Genessa M Smith; Ross A Fredenburg; Ross L Stein; Jong-Beak Park; Xiaochuan Feng; Charles B Shoemaker; Sharad S Deshpande; Michael C Goodnough; Carl J Malizio; Eric A Johnson; Sabine Pellett; William H Tepp; Saul Tzipori
Journal:  Toxicon       Date:  2017-07-08       Impact factor: 3.033

8.  Accessing Elaborated 2,1-Borazaronaphthalene Cores Using Photoredox/Nickel Dual-Catalytic Functionalization.

Authors:  Matthieu Jouffroy; Geraint H M Davies; Gary A Molander
Journal:  Org Lett       Date:  2016-03-17       Impact factor: 6.005

9.  Studying a Drug-like, RNA-Focused Small Molecule Library Identifies Compounds That Inhibit RNA Toxicity in Myotonic Dystrophy.

Authors:  Suzanne G Rzuczek; Mark R Southern; Matthew D Disney
Journal:  ACS Chem Biol       Date:  2015-09-28       Impact factor: 5.100

Review 10.  Treatment of adult and pediatric high-grade gliomas with Withaferin A: antitumor mechanisms and future perspectives.

Authors:  Megan M Marlow; Sumedh S Shah; Eduardo A Véliz; Michael E Ivan; Regina M Graham
Journal:  J Nat Med       Date:  2016-07-02       Impact factor: 2.343
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.